Which hedge funds own ORIC? ORIC PHARMACEUTICALS INC, Q2 2026 13F holders
40 tracked hedge funds disclosed a position in ORIC (ORIC PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $515.9m in total. The largest holder by portfolio weight is AIHC Capital Management Ltd at 39.8% of its book. 7 opened a new position this quarter: Jones Hill Capital LP, Caption Management, LLC, Engineers Gate Manager LP, Squarepoint Ops LLC. 15 exited: Logos Global Management LP, Paradigm Biocapital Advisors LP, Sofinnova Investments, Inc..
- 40
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 7
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 15
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $19.8m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $58.6m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $516m
- Combined value Sum of the holders' reported positions in the security.
- 3.2%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Logos Global Management LP | 0.6% | $12.0m |
| Paradigm Biocapital Advisors LP | 0.4% | $21.6m |
| Sofinnova Investments, Inc. | 0.4% | $8.6m |
| DAFNA Capital Management LLC | 0.2% | $945k |
| Polar Capital Holdings Plc | 0.03% | $6.8m |
| Moore Capital Management, LP | 0.03% | $755k |
| Y-Intercept (Hong Kong) Ltd | 0.03% | $1.4m |
| ExodusPoint Capital Management, LP | 0.02% | $2.4m |
| Campbell & CO Investment Adviser LLC | 0.02% | $378k |
| Boothbay Fund Management, LLC | 0.02% | $785k |
| SummitTX Capital, L.P. | 0.02% | $538k |
| Graham Capital Management, L.P. | 0.01% | $373k |
| Gsa Capital Partners LLP | 0.01% | $162k |
| Alyeska Investment Group, L.P. | 0.0% | $1.7m |
| Hudson Bay Capital Management LP | 0.0% | $157k |
Ownership over time
Who discovered ORIC first? Beta
| Prosight Management, LP high conviction | Q4 2022 | +4.0 pts |
| Silverarc Capital Management, LLC | Q2 2022 | +3.7 pts |
| Venrock Adviser, LLC high conviction | Q2 2023 | +0.8 pts |
| Superstring Capital Management LP high conviction | Q3 2024 | +0.1 pts |
| Frazier Life Sciences Management, L.P. | Q1 2024 | −0.3 pts |
| Orbimed Advisors LLC | Q2 2020 | −0.7 pts |
| Commodore Capital LP | Q1 2024 | −1.1 pts |
| EcoR1 Capital, LLC high conviction | Q2 2020 | −3.3 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.